Nektar Therapeutics
NKTR
NKTR
123 hedge funds and large institutions have $106M invested in Nektar Therapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 124 → 123 (-1)
60% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 50
Holders
123
Holding in Top 10
1
Calls
$449K
Puts
$8K
Top Buyers
| 1 | +$3.74M | |
| 2 | +$3.25M | |
| 3 | +$2.31M | |
| 4 |
SC
Shay Capital
New York
|
+$1.94M |
| 5 |
Millennium Management
New York
|
+$1.3M |
Top Sellers
| 1 | -$3.05M | |
| 2 | -$2.29M | |
| 3 | -$2.27M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.45M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.39M |